| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
|
Blood
|
2000
|
9.60
|
|
2
|
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
|
Proc Natl Acad Sci U S A
|
1990
|
3.03
|
|
3
|
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
|
Blood
|
1997
|
2.82
|
|
4
|
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.
|
Nat Genet
|
1996
|
2.78
|
|
5
|
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.
|
Blood
|
2001
|
2.53
|
|
6
|
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.
|
Blood
|
2001
|
2.52
|
|
7
|
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
|
Blood
|
1999
|
2.31
|
|
8
|
Methylation profiling in acute myeloid leukemia.
|
Blood
|
2001
|
2.22
|
|
9
|
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
|
Blood
|
1998
|
2.17
|
|
10
|
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.
|
Leukemia
|
2003
|
1.97
|
|
11
|
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|
Cancer Res
|
1996
|
1.82
|
|
12
|
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
|
Blood
|
1993
|
1.76
|
|
13
|
Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders?
|
Med Pediatr Oncol
|
2000
|
1.71
|
|
14
|
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
|
Exp Hematol
|
2001
|
1.63
|
|
15
|
Aggressive jejunal lymphoma of large granular lymphocytes. Immunohistochemical, ultrastructural, molecular, and DNA content analysis.
|
Am J Clin Pathol
|
1990
|
1.42
|
|
16
|
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
|
Leukemia
|
2010
|
1.42
|
|
17
|
Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr.
|
Immunity
|
2001
|
1.27
|
|
18
|
Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
|
Hum Pathol
|
1993
|
1.13
|
|
19
|
Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction.
|
Diagn Mol Pathol
|
2000
|
1.11
|
|
20
|
Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr.
|
J Exp Med
|
2000
|
1.11
|
|
21
|
Cloning of the murine c-fgr proto-oncogene cDNA and induction of c-fgr expression by proliferation and activation factors in normal bone marrow-derived monocytic cells.
|
Oncogene
|
1989
|
1.09
|
|
22
|
The case for American Board of Pathology certification in molecular pathology.
|
Hum Pathol
|
1995
|
1.08
|
|
23
|
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.
|
Leuk Res
|
2003
|
1.05
|
|
24
|
Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells.
|
Proc Natl Acad Sci U S A
|
1987
|
1.05
|
|
25
|
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
|
Blood
|
1990
|
1.05
|
|
26
|
Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1).
|
Gene
|
1999
|
1.03
|
|
27
|
False-positive flow cytometric platelet glycoprotein IIb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts.
|
Blood
|
1992
|
1.02
|
|
28
|
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
|
Blood
|
1995
|
1.00
|
|
29
|
Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
|
Genes Chromosomes Cancer
|
1996
|
1.00
|
|
30
|
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
|
Blood
|
1997
|
0.99
|
|
31
|
Trisomy 6 as a primary karyotypic aberration in hematologic disorders.
|
Cancer Genet Cytogenet
|
1998
|
0.98
|
|
32
|
Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
|
Blood
|
1995
|
0.98
|
|
33
|
Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific.
|
Leuk Res
|
2001
|
0.98
|
|
34
|
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report.
|
Leukemia
|
2012
|
0.98
|
|
35
|
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
|
Leukemia
|
2006
|
0.97
|
|
36
|
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line.
|
Genomics
|
1995
|
0.96
|
|
37
|
Acute myelogenous leukemia and aging. Clinical interactions.
|
Hematol Oncol Clin North Am
|
2000
|
0.94
|
|
38
|
Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
|
Clin Cancer Res
|
1999
|
0.91
|
|
39
|
Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia.
|
Leukemia
|
2007
|
0.91
|
|
40
|
Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
|
Leukemia
|
1999
|
0.88
|
|
41
|
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction.
|
J Mol Diagn
|
2001
|
0.87
|
|
42
|
Trisomy 11: an association with stem/progenitor cell immunophenotype.
|
Br J Haematol
|
1995
|
0.86
|
|
43
|
Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
|
Leuk Res
|
1998
|
0.86
|
|
44
|
Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
|
Blood
|
1998
|
0.86
|
|
45
|
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
|
Leukemia
|
2006
|
0.84
|
|
46
|
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.
|
Lancet
|
1994
|
0.83
|
|
47
|
Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature.
|
Leukemia
|
2000
|
0.82
|
|
48
|
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.
|
Leukemia
|
2011
|
0.82
|
|
49
|
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
|
Blood
|
1995
|
0.82
|
|
50
|
Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells.
|
Leukemia
|
1999
|
0.82
|
|
51
|
Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.
|
Leukemia
|
1995
|
0.81
|
|
52
|
Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia.
|
Cancer Epidemiol Biomarkers Prev
|
2000
|
0.80
|
|
53
|
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.
|
Blood
|
2000
|
0.80
|
|
54
|
Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.
|
Leukemia
|
1996
|
0.79
|
|
55
|
The function of src family tyrosine kinases in hematopoietic cells.
|
Leuk Res
|
1996
|
0.79
|
|
56
|
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.
|
Leuk Res
|
2000
|
0.78
|
|
57
|
Molecular biology and the pathologist. General principles and applications.
|
Arch Pathol Lab Med
|
1987
|
0.78
|
|
58
|
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein.
|
Blood
|
1998
|
0.78
|
|
59
|
Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
|
Leukemia
|
1991
|
0.78
|
|
60
|
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
|
Leuk Res
|
2001
|
0.78
|
|
61
|
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17).
|
Leukemia
|
2000
|
0.77
|
|
62
|
Oncogenes, suppressor genes, and carcinogenesis.
|
Hum Pathol
|
1987
|
0.77
|
|
63
|
Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials.
|
Leukemia
|
2006
|
0.76
|
|
64
|
Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia.
|
Genes Chromosomes Cancer
|
2000
|
0.76
|
|
65
|
Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
|
Leukemia
|
1999
|
0.75
|
|
66
|
A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteins.
|
Am J Clin Pathol
|
1992
|
0.75
|
|
67
|
The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
|
Leuk Lymphoma
|
1996
|
0.75
|
|
68
|
p73 mutations and expression in adult de novo acute myelogenous leukemia.
|
Leukemia
|
1999
|
0.75
|
|
69
|
Isolation and characterization of the murine C-FGR genomic locus: exons IB-XII.
|
Oncogene
|
1995
|
0.75
|
|
70
|
Prognostic markers in acute leukemia.
|
Curr Opin Hematol
|
1996
|
0.75
|
|
71
|
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings.
|
Diagn Mol Pathol
|
1994
|
0.75
|